Ananke Therapeutics

United States
Is it you?
Investor info
Type
Venture Capital
Stage focus
  • Early stage VC
Description
Ananke Therapeutics is a biopharmaceutical company focused on developing innovative therapies to address unmet medical needs, particularly in the field of oncology. They leverage advanced research and development to create novel treatments aimed at improving patient outcomes.
Relevant investments
  • Company
    Amount
    Round
  • Example example company Inc
    1000000
    Investor meetings
  • Company & Company
    11000000
    Series C funding
  • Example
    524000
    Seed round A
Show more
Connected people
Email visible after logging in
  • Example Example
    Example Exampleexample[email protected]
  • Example Exampleexample
    Example Exampleexample
  • Notexample Examplenot
    Notexample Examplenotexample example[email protected]
  • Example Examplenotexample
    Example Examplenotexampleexample example[email protected]
  • Example Example
    Example Exampleexample[email protected]
  • Example Example
    Example Exampleexample[email protected]
Show more
See other investors
Made with in San Francisco, Valencia, Oslo, Cherkasy and Warsaw© 2015-     Foundersuite, Inc.